» Articles » PMID: 36061155

Endothelial and Microvascular Function in Liver Cirrhosis: an Old Concept That Needs Re-evaluation?

Overview
Specialty Gastroenterology
Date 2022 Sep 5
PMID 36061155
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cirrhosis is characterized by significant circulatory dysregulation, related to an imbalance among several vasodilating agents, mainly nitric oxide. In contrast to portal vein and macrovascular hemodynamic alterations, which have been rather well described, the peripheral microcirculatory and endothelial structure and function in this population are less well studied. Endothelial dysfunction is characterized by an imbalance between endothelium-derived relaxing and contracting factors. A number of methods have been used to assess endothelial and microvascular function in human studies. Venous occlusion plethysmography was used for many years as the gold standard for evaluating endothelial function, but flow-mediated dilatation (FMD) of the forearm is currently the most frequently used method. In patients with cirrhosis, the few existing studies have mainly used FMD, but the relevant results are largely contradictory. In recent years, several noninvasive and easily applicable methods, such as near-infrared spectroscopy, laser speckle contrast imaging, peripheral arterial tonometry, optical coherence tomography and nailfold video-capillaroscopy, have been increasingly used to assess peripheral microvascular function and have demonstrated a number of advantages. In this review, we present functional methods to evaluate peripheral microvascular and endothelial function, and we discuss the existing evidence on circulatory dysfunction in patients with liver cirrhosis.

Citing Articles

Endothelial Dysfunction and Liver Cirrhosis: Unraveling of a Complex Relationship.

Nesci A, Ruggieri V, Manilla V, Spinelli I, Santoro L, Di Giorgio A Int J Mol Sci. 2024; 25(23).

PMID: 39684569 PMC: 11640898. DOI: 10.3390/ijms252312859.


Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.

Liu P, Liang W, Huang R, Chen X, Zou D, Kurihara H Front Pharmacol. 2024; 15:1399598.

PMID: 39108760 PMC: 11300221. DOI: 10.3389/fphar.2024.1399598.


Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis.

Efremova I, Maslennikov R, Poluektova E, Medvedev O, Kudryavtseva A, Krasnov G Int J Mol Sci. 2024; 25(4).

PMID: 38396668 PMC: 10888218. DOI: 10.3390/ijms25041988.


Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.

Liu H, Nguyen H, Hwang S, Lee S Int J Mol Sci. 2023; 24(23).

PMID: 38069125 PMC: 10706054. DOI: 10.3390/ijms242316805.


Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia.

Gaggini M, Gorini F, Vassalle C Int J Mol Sci. 2023; 24(1).

PMID: 36613514 PMC: 9820080. DOI: 10.3390/ijms24010075.

References
1.
Cazzaniga M, Salerno F, Visentin S, Cirello I, Donarini C, Cugno M . Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index. Liver Int. 2008; 28(10):1396-401. DOI: 10.1111/j.1478-3231.2008.01847.x. View

2.
Ferrari M, Quaresima V . A brief review on the history of human functional near-infrared spectroscopy (fNIRS) development and fields of application. Neuroimage. 2012; 63(2):921-35. DOI: 10.1016/j.neuroimage.2012.03.049. View

3.
Tsochatzis E, Bosch J, Burroughs A . Liver cirrhosis. Lancet. 2014; 383(9930):1749-61. DOI: 10.1016/S0140-6736(14)60121-5. View

4.
Hoong C, Tan M, Kao S, Khoo E . Effects of external counter-pulsation on endothelial function assessed by peripheral artery tonometry, levels of glycaemia and metabolic markers in individuals with type 2 diabetes mellitus. Diabetes Metab Syndr. 2020; 14(6):2139-2145. DOI: 10.1016/j.dsx.2020.11.003. View

5.
Iwakiri Y, Groszmann R . Vascular endothelial dysfunction in cirrhosis. J Hepatol. 2007; 46(5):927-34. DOI: 10.1016/j.jhep.2007.02.006. View